UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 2017, Volume 61, Issue 10
Antifungal resistance | Sporothrix | ECVs | Molecular methods | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Sporothrix - isolation & purification | Lipopeptides - pharmacology | Humans | Amphotericin B - pharmacology | Sporothrix - drug effects | Naphthalenes - pharmacology | Microbial Sensitivity Tests | Triazoles - pharmacology | Sporothrix - classification | Sporotrichosis - drug therapy | Flucytosine - pharmacology | Echinocandins - pharmacology | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 12/2015, Volume 59, Issue 12, pp. 7882 - 7887
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Mucorales - isolation & purification | Nitriles - pharmacology | Species Specificity | Voriconazole - pharmacology | Humans | Amphotericin B - pharmacology | Mucorales - drug effects | Mucorales - growth & development | Mucorales - classification | Triazoles - pharmacology | Microbial Sensitivity Tests - standards | Mucormycosis - microbiology | Pyridines - pharmacology | Mucormycosis - drug therapy | Microbial Sensitivity Tests - methods | Index Medicus | Susceptibility
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6441 - 6450
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Polymyxin B - pharmacology | Biguanides - pharmacology | Acanthamoeba - metabolism | Cefazolin - pharmacology | Infectious Encephalitis - parasitology | Acanthamoeba - drug effects | Lipopeptides - pharmacology | Humans | Amphotericin B - pharmacology | Chlorhexidine - pharmacology | Acanthamoeba Keratitis - drug therapy | Thienamycins - pharmacology | Azoles - pharmacology | Infectious Encephalitis - drug therapy | Antiprotozoal Agents - pharmacology | Natamycin - pharmacology | Acanthamoeba - growth & development | Animals | Acanthamoeba Keratitis - parasitology | Antiprotozoal Agents - chemical synthesis | Echinocandins - pharmacology | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 11/2014, Volume 58, Issue 11, pp. 6934 - 6937
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Cunninghamella - drug effects | Nitriles - pharmacology | Lipopeptides - pharmacology | Amphotericin B - pharmacology | Aspergillus - drug effects | Microbial Sensitivity Tests | Triazoles - pharmacology | Deoxycholic Acid - pharmacology | Drug Interactions | Aspergillosis - microbiology | Pyridines - pharmacology | Mucormycosis - drug therapy | Drug Combinations | Echinocandins - pharmacology | Aspergillosis - drug therapy | Index Medicus | Pharmacology
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 03/2016, Volume 76, Issue 4, pp. 485 - 500
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Tissue Distribution | Animals | Chemistry, Pharmaceutical - methods | Deoxycholic Acid - pharmacology | Humans | Amphotericin B - pharmacology | Half-Life | Amphotericin B - pharmacokinetics | Clinical Trials as Topic | Deoxycholic Acid - pharmacokinetics | Drug Combinations
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 4, pp. 328 - 341
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Biological and medical sciences | General aspects | Infectious diseases | Medical sciences | Epidemiology. Vaccinations | United States - epidemiology | Prevalence | Gram-Positive Bacteria - drug effects | Humans | Tobramycin - pharmacology | Drug Resistance, Bacterial | Intensive Care Units - statistics & numerical data | Disease Transmission, Infectious - prevention & control | Cross Infection - transmission | Polymyxins - pharmacology | Digestive System - drug effects | Decontamination | Gentamicins - pharmacology | Vancomycin - pharmacology | Neomycin - pharmacology | Nystatin - pharmacology | Odds Ratio | Cephalosporins - pharmacology | Cross Infection - epidemiology | Oropharynx - microbiology | Anti-Infective Agents, Local - pharmacology | Cross Infection - prevention & control | Methicillin-Resistant Staphylococcus aureus - drug effects | South Africa - epidemiology | Amphotericin B - pharmacology | Europe - epidemiology | Clinical Trials as Topic | Pseudomonas aeruginosa - drug effects | Cross Infection - drug therapy | Randomized Controlled Trials as Topic | Gram-Negative Bacteria - drug effects | Anti-Infective Agents, Local - administration & dosage | Cross Infection - microbiology | Fluoroquinolones - pharmacology | Enterobacteriaceae - drug effects | Primary Prevention - methods | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Anti-Bacterial Agents - administration & dosage | Digestive System - microbiology | Oropharynx - drug effects | Drug resistance in microorganisms | Analysis | Index Medicus | Antimicrobial agents
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2011, Volume 55, Issue 10, pp. 4652 - 4658
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Fluconazole - pharmacology | Pseudallescheria - drug effects | Lipopeptides - pharmacology | Humans | Scedosporium - drug effects | Fusarium - drug effects | Paecilomyces - drug effects | Itraconazole - pharmacology | Microbial Sensitivity Tests | Voriconazole | Antifungal Agents - toxicity | Echinocandins - pharmacology | Antifungal Agents - pharmacology | Aminopyridines - toxicity | Cell Line | Fungi - drug effects | Amphotericin B - pharmacology | Pyrimidines - pharmacology | Yeasts - drug effects | Aspergillus - drug effects | Isoxazoles - pharmacology | Triazoles - pharmacology | Aminopyridines - pharmacology | Candida - drug effects | Isoxazoles - toxicity | Index Medicus | Toxicity | Antifungal agents | Molds | Cytotoxicity | Fungi | Infection | Antifungal activity | fluconazole | Amphotericin B | Minimum inhibitory concentration | micafungin | Itraconazole | Susceptibility
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 2016, Volume 60, Issue 6, pp. 3372 - 3379
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Fluconazole - pharmacology | Voriconazole - pharmacology | Lipopeptides - pharmacology | Humans | Amphotericin B - pharmacology | Neoplasm Proteins - metabolism | ATP Binding Cassette Transporter, Sub-Family G, Member 2 - metabolism | Itraconazole - pharmacology | Triazoles - pharmacology | ATP Binding Cassette Subfamily B Member 11 | HEK293 Cells | ATP Binding Cassette Transporter, Sub-Family B - metabolism | ATP-Binding Cassette Transporters - metabolism | Biological Transport - drug effects | Itraconazole - analogs & derivatives | Multidrug Resistance-Associated Proteins - metabolism | Echinocandins - pharmacology | Index Medicus
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 06/2013, Volume 73, Issue 9, pp. 919 - 934
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Amphotericin B - adverse effects | Antifungal Agents - pharmacology | Antifungal Agents - adverse effects | Lipids - chemistry | Animals | Chemistry, Pharmaceutical - methods | Fungi - drug effects | Humans | Amphotericin B - pharmacology | Mycoses - drug therapy | Antifungal Agents - chemistry | Amphotericin B - chemistry
Journal Article